Nairametrics
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
  • Markets
    • Cryptos
    • Commodities
    • Equities
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Industries
    • Company News
    • Consumer Goods
    • Content Partners
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Tech News
  • Economy
    • Get Data
    • Macro-Economic News
    • Research Analysis
  • Business News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
No Result
View All Result
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
  • Markets
    • Cryptos
    • Commodities
    • Equities
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Industries
    • Company News
    • Consumer Goods
    • Content Partners
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Tech News
  • Economy
    • Get Data
    • Macro-Economic News
    • Research Analysis
  • Business News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
No Result
View All Result
Nairametrics
No Result
View All Result
Home Business News Coronavirus

Moderna vaccine certified to protect monkeys against Coronavirus during study

Chike Olisah by Chike Olisah
July 29, 2020
in Coronavirus
Moderna COVID-19 vaccine passes safety test on animals
Share on FacebookShare on TwitterShare on Linkedin

American biotechnology firm, Moderna Inc. on Tuesday announced that its COVID-19 vaccine trial recorded a positive outcome. The company said its experimental vaccine induced a robust response and protected against infection in a study on monkeys.

More details: Results of the study which was carried out on rhesus macaque monkeys and published in the New England Journal of Medicine, showed that when given to non-human primates, the vaccine (mRNA-1273) protected against infection in the lungs and nose. It also prevented pulmonary disease in all animals. Scientists have, therefore, certified this an improvement over similar results that were gotten from AstraZeneca’s COVID-19 vaccine study.

READ ALSO: COVID-19: Vaccine Alliance says vaccine might cost a maximum of $40 per dose

RelatedPosts

FG says Nigeria gathering vaccine producers to develop technology in case of future outbreaks

You can now go to United States without COVID-19 tests

Meanwhile, as a follow up to the positive results of the animal study recorded by Moderna, the firm has already begun experimental testing on humans.

Nairametrics also understands that the firm commenced another study to test its RNA vaccine against a placebo in 30,000 healthy volunteers, according to a report by Reuters. It is expected that a positive outcome from the new trial would expedite the regulatory approval process for mass usage of the vaccine.

Important things to note about the study

  • The study involves 24 monkeys
  • Moderna tested doses of 10 micrograms or 100 micrograms of the vaccine against no treatment
  • Both doses were certified effective at protecting against viral replication in the lungs and lung inflammation
  • Larger doses also protect against viral replication in the nose of the animals.

READ MORE: Covid-19: Oxford-AstraZeneca vaccine shows strong immune response

It should be noted that a more advanced viral vaccine that is being developed by the collaboration of Oxford University and AstraZeneca had, in a similar animal study, demonstrated that it can prevent damage to the lungs and keep the virus from making copies of itself there. However, during the study, the virus still actively replicated in the nose.

Quick Facts: At the moment, there are more than 100 COVID-19 vaccines under different levels of development by pharmaceutical companies, academic institutions, government agencies, and others. The World Health Organization (WHO) is tracking most of these. Tens of such vaccine candidates are already undergoing clinical trials across more than a dozen countries.

READ ALSO: COVID-19: WHO reports highest global daily cases

The backstory: Following a promising result in an early human trial, Moderna launched large scale testing, involving 30,000 participants. The Chinese biotech firm CanSino Biologics and the medical research arm of the People’s Liberation Army also started COVID-19 vaccine trials in March which were later approved for use by military personnel in June.

The WHO Chief Scientist has said that the vaccine, which is manufactured by AstraZeneca in collaboration with the University of Oxford, is likely the world’s leading candidate. Initial human trials are set to begin in the US in August.

America’s pharmaceutical giant Pfizer, Germany’s firm BioNTech, and Chinese firm Fosun Pharma are all working on a vaccine that started human trials in April in Germany and later in the United States.

Related

Tags: AstraZeneca PlcBioNTechBusiness NewsCoronavirusModerna IncPfizerWorld Health Organization WHO

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Mega Millions
Hot forex
Cornerstone
Polaris Bank
Access Bank
Bankers Committee
First bank


FCMB
Ikeja Electrics




    Business News | Stock Market | Money Market | Cryptos | Financial Literacy | SME |

    Recent News

    • This is Bitcoin’s worst quarter in 11 years
    • Despite Reports, El Salvador Doubles Down on Bitcoin Bet to the Tune of $1.5 Million
    • US government places $100,000 bounty on “cryptoqueen”, Ruja Ignatova, for $4 billion crypto scam

    Follow us on social media:

    Recent News

    Bitcoin falls against Russia-Ukraine war

    This is Bitcoin’s worst quarter in 11 years

    July 1, 2022
    Bitcoin takes off as El Salvador adopts it as legal tender

    Despite Reports, El Salvador Doubles Down on Bitcoin Bet to the Tune of $1.5 Million

    July 1, 2022
    • ABOUT US
    • CONTACT US
    • PRODUCTS
    • ANDROID APP
    • iOS APP
    • DISCLAIMER
    • CAREERS
    • PRIVACY POLICY

    © 2022 Nairametrics

    No Result
    View All Result
    • Home
    • Exclusives
      • Financial Analysis
      • Corporate Stories
      • Interviews
      • Investigations
      • Metrics
    • Markets
      • Cryptos
      • Commodities
      • Equities
        • Dividends
        • Stock Market
      • Fixed Income
      • Market Views
      • Securities
    • Industries
      • Company News
      • Consumer Goods
      • Content Partners
      • Corporate deals
      • Corporate Press Releases
      • Energy
      • Entertainment
      • Financial Services
      • Hospitality & Travel
      • Manufacturing
      • Real Estate and Construction
      • Tech News
    • Economy
      • Get Data
      • Macro-Economic News
      • Research Analysis
    • Business News
    • Financial Literacy
      • Career tips
      • Personal Finance
    • Lifestyle
      • Billionaire Watch
      • Profiles
    • Opinions
      • Blurb
      • Op-Eds

    © 2022 Nairametrics

    Social Media Auto Publish Powered By : XYZScripts.com